Task: Answer the multiple-choice question.
Query: Which compound exhibits a -18.821% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: Cc1ccc2nc(SCC(=O)Nc3cccc(F)c3)nc(=O)n2c1
b: Cc1cc(NC(=O)CCN2CCN(CCO)CC2)ccc1Br.Cl
c: COc1ccc(-c2cc(-c3ccccc3)c(C#N)c(S(C)=O)n2)cc1
Answer: a. Cc1ccc2nc(SCC(=O)Nc3cccc(F)c3)nc(=O)n2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2nc(SCC(=O)Nc3cccc(F)c3)nc(=O)n2c1
Cc1ccc2nc(SCC(=O)Nc3cccc(F)c3)nc(=O)n2c1
N-(3-fluorophenyl)-2-(7-methyl-4-oxopyrido[1,2-a][1,3,5]triazin-2-yl)sulfanylacetamide